Derrick Sung - 01 Jun 2021 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role: Chief Financial Officer
Signature: /s/ Lauren Cristina, Attorney-in-Fact for Derrick Sung
Issuer symbol: LUNG
Transactions as of: 01 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 11 Jun 2021, 20:24:31 UTC
Next filing: 03 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LUNG	Common Stock	Award	$0	+17,600	+8%	$0.000000	238,186	01 Jun 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LUNG	Employee Stock Option (right to buy)	Award	$0	+39,900		$0.000000	39,900	01 Jun 2021	Common Stock	39,900	$43.40	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on June 1, 2021.
F2	Includes 1,927 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on May 24, 2021.
F3	The shares subject to the option vest in 48 equal monthly installments beginning on June 1, 2021.